Companies: 10,795·Total market cap: $144.5T
Coloplast A/S

Coloplast A/S

CLPBYOTCHealthcare● Active
$5.94
$-0.02(-0.34%)
Market Cap$13.4B
P/E Ratio
52W High$10.03
52W Low$5.88

Coloplast A/S (CLPBY) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

CLPBY · shares outstanding · updated Jun 9, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
2.254B +0.21% YoY Change
FY · as of Sep 30, 2025 · Reported in DKK
vs 2.249B in FY 2024
Diluted Shares Outstanding
2.254B
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
+0.21%
year-over-year
Float (Free Float)
143.4M
publicly tradable shares
6.4% of total
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-09

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+2.0%
2022 → 2025
5-Year CAGRincreasing
+1.2%
2020 → 2025
10-Year CAGRincreasing
+0.7%
2015 → 2025

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2025Latest
Diluted Shares: 2.254B
2.254B
+0.21%
FY 2024
Diluted Shares: 2.249B
2.249B
+4.41%
FY 2023
Diluted Shares: 2.155B
2.154B
+1.36%
FY 2022
Diluted Shares: 2.128B
2.125B
-0.14%
FY 2021
Diluted Shares: 2.132B
2.128B
+0.09%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs CLPBY
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+11.0%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+7.8%
#3
Coloplast A/SCLPBY
Coloplast A/SYOU
2.254B
#4
AbbVie Inc.ABBV
AbbVie Inc.
1.780B-21.0%
#5
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B-31.2%
#6
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M-59.6%
#7
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M-60.2%

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

Coloplast A/S (CLPBY) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of September 30, 2025, Coloplast A/S reports 2.254B basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

Coloplast A/S's basic shares outstanding (2.254B) represents currently issued shares. Diluted shares outstanding (2.254B) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

Coloplast A/S's float is 143.4M (6.4% of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float143.4M(6.4%)
Outstanding2.254B

Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · DKK

About shares outstanding & methodology

Coloplast A/S (CLPBY) shares outstanding history from 2006 to 2025. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

Coloplast A/S shares outstanding for the fiscal year ending September 30, 2025 were 2.254B, a 0.21% increase year-over-year. Coloplast A/S FY 2025 shares outstanding were 2.254B, a +0.21% increase from FY 2024.

Coloplast A/S is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of +0.7% — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.

Frequently asked questions

CLPBY shares outstanding · 4 questions

As of September 30, 2025, Coloplast A/S (CLPBY) has approximately 2.254B basic shares outstanding and 2.254B diluted shares outstanding. This represents a +0.21% year-over-year increase from FY 2024 (2.249B). The increase may reflect equity compensation issuances or secondary offerings.

CLPBY shares outstandinghow many shares does CLPBY haveCLPBY basic shares 2025CLPBY diluted shares

Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · Coloplast A/S SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-09